E
ICVX

Ergoteles’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Ergoteles’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,709
Closed -$236K – 1908
2022
Q4 		$236K Buy
+29,709
New +$128K 0.01% 1007

Other funds holding ICVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Ergoteles's ICVX Position: Q1 2023 in Review

Ergoteles sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2023, closing a stake of 29,709 shares — an estimated $236K sold.

Ergoteles first reported a position in ICVX in Q4 2022 and held it in 1 quarter. The position peaked at $236K in Q4 2022. 66 funds tracked by Wall St. Rank hold ICVX as of Q1 2023.

  • Ergoteles reported no remaining Icosavax, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Ergoteles sold 29,709 Icosavax, Inc. Common Stock shares in Q1 2023, an estimated $236K.
  • Ergoteles first reported a position in Icosavax, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Ergoteles's Icosavax, Inc. Common Stock position peaked at $236K in Q4 2022.
  • 66 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.